Post oral argument comments on Mutual Pharma v. Bartlett

The big news in torts last month was the oral argument before the US Supreme Court in Mutual Pharmaceutical v. Bartlett which asks the Court to decide whether a generic drug maker can be held liable for a design defect.  I wrote about it here, here, here, here and here.  For even more on the issues related to generic manufacturers, products liability and warnings cases, click on the "labels" below this post.

Just a few days ago, the SCotUS blog published a detailed look at the argument here.